Phase 2 OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years of age
- People whose primary diagnosis is obsessive-compulsive disorder (OCD)
- People whose OCD symptoms are severe enough to meet the trial's threshold (confirm with trial site)
- People who are able to go through a period without treatment as part of the study
- People who are able to understand and agree to what participation involves
Who may not be able to join:
- People with certain mental health or physical health conditions that could make participation unsafe (confirm with trial site)
- People who are currently pregnant or breastfeeding
- People who are currently taking medications that could interact with the trial treatment or otherwise increase the risks of participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peter J van Roessel, MD, PhD, Stanford Univeristy
Phone: 650-723-4095
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improvement in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.